StockMidas

Author Archives

Guru-ish Pundits

I have come to realize more so everyday – disregard mainstream analysts, Wall Street recommendations, and even MorningStar ratings, due to the inherent conflict of interest between the firms and their particular clientèle. Here is the point: YOU, are NOT Wall Street’s client. YOU are the CONSUMER of the products sold FOR Wall Street’s clients. […]

Guru-ish Pundits

I have come to realize more so everyday – disregard mainstream analysts, Wall Street recommendations, and even MorningStar ratings, due to the inherent conflict of interest between the firms and their particular clientèle. Here is the point: YOU, are NOT Wall Street’s client. YOU are the CONSUMER of the products sold FOR Wall Street’s clients. […]

Recent Author Comments

On Yastine's "$5 Biotech Stock Revolutionizing Health Care"
The "news" of Opiant's revolutionary Narcan Spray designed for reversing the effects of an opiate overdose broke in the first part of 2017. The stock price ramped up from $ 6 to $50 within a space of two months,only to tank down again and has been trading[...]
On What's Schaefer's "My Greatest Winner of All Time Will NOT Be an Oil or Gas Stock" tease all about?
As per the issues alluded to by Travis TrackX Holdings Inc. (TKXHF) may not make too much sense fundamentally now, but from a technical point of view quite attractive: * Has just broken through resistance and 200MA in concerted upward momentum of 75 +; * A[...]
On Fool's "The Tiny Black Box That Could Eliminate Cable" and "Cable TV's Ticking Time Bomb" teasers
Motley Fool has been advocating The Trade Desk, Inc. (TTD) for some time. I tend to agree with Travis on the attractive medium / long term prospects of TTD. Market cap of $6 Bill with average trading volume of 1 Mill. Technically sound, since enterin[...]
On What's Ernie Tremblay's $7 Prostate Cancer Fighter?
Agree with Hugh R, technically leaning more towards cold than luke warm. Trading above 200MA but below 50MA & 100MA, with narrow association between signal and divergence in a lateral movement on MACD with reduced trading volumes indicative of a continued[...]
On Friday File: Diving into another Marijuana teaser, plus several add-on buys
These days there are umpteen articles, publications and discussion groups on Pot Stocks, with new ones seeing the light daily in anticipation of the legalization of recreational use of Cannabis in Canada on 17 October 2018. The general consensus, especiall[...]
On What's "The Pot Stock of the Decade" pitched by The Wealth Advisory?
The Pot is certainly Cooking - it is without a doubt the hottest and most talked about sector. Motley Fool recently published the Five Marijuana Stocks With the Highest Expected Sales Next Year: 1. Canopy Growth Corp. (CGC) : $687.8 million 2. Aphria [...]
On Friday File: What's that "Cancer Sniper" Stock promising a "5,320% Bonanza?"
Genprex, Inc. (GNPX) - Rodney Varner, Chairman and CEO, remarked during the recent Clinical and Corporate Update for Second Quarter 2018: “We have made significant progress in recent months to advance the development of Oncoprex™ for treatment of non-s[...]
On What the heck is "Brandt Oil?"
Thx deanbob, will certainly go that route when my current subscription expires.[...]
On What the heck is "Brandt Oil?"
Hi Travis So I have the choice to subscribe to Forest’s letter for $2000; or yours for $59 / annum (which I have just renewed after the first year) only to find out that from yours now (@ $59) advising against investing in ECSIF or later from Forrests[...]
On "Hyper-X" Weapons and "The Next Cold War"
Comprehensive recount Travis, thx ... Aerojet Rocketdyne Holdings, Inc. (AJRD) is one of the more attractive opportunities touted by the pundits lately soliciting subscriptions. Operating in an industry that attracts continued attention on account of wo[...]
On Friday File: Turmoil in Tech-Land, earningspalooza continues, plus some small buys and a couple new watchlist stocks
AMZN is and remains one of the most amazing companies in the world. It churns out impressive earnings out time and again. A stock that trades uninterrupted above 200MA for 3½ years with continued upward momentum is a feat on its own. Making a statemen[...]
On Stansberry Venture's "Most Valuable Pill in Development, Anywhere" pitch
I am subscribed to Oxford Club - Why? - No one knows. Their site is so convoluted, incomprehensible and totally impenetrable that it is impossible to find the said punt. The only accessibility is for solicitation to subscribe to more of their guruish punts[...]
On Stansberry Venture's "Most Valuable Pill in Development, Anywhere" pitch
It will be a discovery of majestic proportions to discover a drug which is effective for dyslipidaemias - incorrect / elevated ratios of the sub-fractions of cholesterol since the total cholesterol value per-se should be of limited significance whether tre[...]
On Alex Green's "No. 1 Stock in 2019" -- $3 "Single Stock Retirement Plan" trading under a "Secret Name"
Hon Hai Precision Industry Co., Ltd. (HNHPF) traded in Aug 2008 at ± $6.00. It closed today (i.e. 10 years later) at $5.43. From 52 week high in Aug 2017 it has retraced by 35% to current levels. Despite market cap of $48 Bill still trading on OTC mar[...]
On Friday File: Portfolio Transactions Catch-up (2 sells, 5 buys)
Deanbob, regrettably all businesses and enterprises will be affected. South Africa is literally a boiling pot tethering on the brink of boiling over. With the EFF (Economic Freedom Fighters), one of the extremist opposition parties pushing very hard for a [...]
On Friday File: Portfolio Transactions Catch-up (2 sells, 5 buys)
Naspers (the name derived from Nasional Pers, meaning National Media) hails from my native country, South Africa. With a 20% pullback since mid January 2018 may seem like a good entry point but in my humble opinion is not investable now. Trading in the “[...]
On Friday File: Operation SPARCSTAR!
Hillary Kramer has been punting GWPH for some time as well., which was featured on StockGumshoe in March 2017: https://www.stockgumshoe.com/reviews/gamechangers-2/kramer-if-you-dont-take-a-small-position-in-this-marijuana-stock-youll-regret-it-for-the-res[...]
On Friday File: Operation SPARCSTAR!
Hi Dana Send me an e-mail to info@stockmidas.com - will forward you an evaluation report on WNDW.[...]
On Friday File: Operation SPARCSTAR!
In the late 2016’s SCON retraced from $3.50 levels down to trading around the $1.00 mark where it has been trading sideways for 18 months ever since, having closed at exactly $1.00 yesterday. A concern is that since it trades on the Nasdaq in the eve[...]
On One More Dance with Dr. Al Sears … and a Bit of Genuinely Good News
Dear Griffin As an early retired MD / anesthetist (now thankfully full time trader .. lol) I can assure you that the symptoms from heart and lung disease can certainly be confused. If you consider the physiology of the human body – in very simple terms t[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch